Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Houdé is a historic French pharmaceutical company, now a subsidiary of Sanofi, best known for its development and commercialization of Colchicine Houdé. Founded in 1892 by Henri Houdé, the company specialized in the extraction and formulation of plant-based alkaloids, establishing itself as a leader in rheumatology treatments. Its flagship product, Colchicine Houdé, remains a global standard for the treatment of acute gout attacks and the prevention of inflammatory conditions such as Familial Mediterranean Fever. Over the decades, the company was integrated into the Roussel Uclaf group, which eventually became part of the Sanofi conglomerate through a series of mergers. Today, the Houdé brand continues to operate as a specialized unit within Sanofi, managing a portfolio of established essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Houde Labs.